Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B - Wikidata - wikimedia - TriplyDB

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

http://www.wikidata.org/entity/Q33787916

about

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Chronic hepatitis C and liver fibrosis.Clinical applications of transient elastography Evaluation of liver fibrosis: "Something old, something new…"Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics.Non-invasive assessment of liver fibrosis in chronic hepatitis B.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.Non-invasive diagnosis of hepatitis B virus-related cirrhosis Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS.Noninvasive tools to assess hepatic fibrosis: ready for prime time?FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.Meta-analyses of FibroTest diagnostic value in chronic liver disease.Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study.Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy.Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease.Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.Noninvasive assessment of liver damage in chronic hepatitis B.Monitoring during and after antiviral therapy for hepatitis B.Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B.Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.Assessment of liver fibrosis: noninvasive means.Implication of normal liver enzymes in liver disease.Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.Biomarkers of liver fibrosis.Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice.Hepatitis B: are non-invasive markers of liver fibrosis reliable?FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Hepatitis B and Schistosoma co-infection in a non-endemic area.Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.

P2860

Q21144283-1FF3FB74-0418-4BE0-840B-5C69ABD5D228 Q26740195-F32CD7EE-1E8C-4DD8-951C-49BA46AAC8AC Q26825671-842E0A91-9BCC-484C-8AC0-F4A821DE9219 Q26828052-BF3BDE22-FB8A-4A42-96D0-323BD5462401 Q28068532-3275F9D5-2369-4397-82C8-843205474C0F Q28084154-6BEC40FF-F8F1-4EFC-B68B-162C2AA8633B Q28479262-236A4896-FF0D-4719-8741-B7908BDCC024 Q30356097-C23B1FF8-9421-4DDF-BD9B-0B23FC64FCB4 Q30427489-9AD14600-B8C4-4134-8FDA-5408E132CE8C Q30430774-639EB237-B98D-4E46-9242-3509DACC20B2 Q30442641-0F489003-FF96-43F2-83FE-834150E59C91 Q30456214-0A86ED06-5C68-4852-A902-BA921FA5D014 Q30464087-8CD78FB8-9E47-48F7-A601-235A94B426A3 Q31170758-D50A4222-56FC-4A9C-A691-820CB7FBCBE5 Q33296508-B1A727CC-E51D-42A8-9911-84BF0DBE8D9D Q33302708-AECA8A63-A9AE-4F65-B555-644A679518E1 Q33612264-DE3CF51C-F2FE-4E70-B52B-347B6CFD4618 Q33671532-090D02D8-FA9A-4882-A680-34A173758297 Q34158701-93DCDB57-3B56-4385-8A6B-3523D367279B Q34892910-1E47F0DC-7F6E-4FF0-8250-721465B26544 Q35194722-749053E6-A834-4DD9-9245-7C3FC2EE748E Q35507424-214B0A0D-D718-47E8-B927-8E5263B5DA5C Q35908687-0FF6099B-2331-4FE0-8715-8D56D1390F2F Q36478140-6F6F8B8E-9584-4B1F-9F82-49BB0748E56F Q37078109-29931AC7-C8BD-4083-B778-677FAEF04361 Q37157860-11176F98-1A4B-43EA-9C1A-FEC18F8BA0BF Q37186162-D79D410D-9D2E-410E-9F8C-54F19C2FBC6F Q37192623-EC096D24-518A-422A-9017-A50D855D2C6F Q37404895-A28A9BBB-3790-4AF6-B58A-D67154FA264A Q37420008-F961FC78-BD5A-45EB-A361-B5CBDE564761 Q37477801-EDA41EA5-04BF-48C7-93C6-47CEFDA1ED03 Q37536973-25CC1D13-B129-4136-9EA0-C71549156CB9 Q37572860-3592910F-3645-474A-9DDF-A6C436AFF796 Q37627015-734F01B4-1E54-4738-9B19-A4B3009965BB Q37825547-33E6DBF8-7F5E-493F-9378-49DBDC405213 Q37928941-EBF883DE-5DC2-4142-82C9-B836A303FF2C Q38174256-B6854BA4-AD1E-4D3F-B531-6F11EEE2217E Q38188809-B783978B-4F65-49A8-998C-576AC3F32C47 Q38957384-46B16AF0-7C49-4C6D-AB24-3EC6F2F3C421 Q40707349-16F3D709-4B03-4A5B-955B-51E115375062

P2860

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

http://www.wikidata.org/entity/Q33787916

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@ast

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@en

type

label

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@ast

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@en

prefLabel

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@ast

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@en

P1433

Q33787916-1DABD859-597F-469C-8230-8DB2F0CA0D45

P1476

Q33787916-939C4C51-F5A5-4272-962F-ADF1E65D1628

P2093

Q33787916-79E7BEEA-B4C5-41C9-ACF2-5B402655166B

Q33787916-A1B504C8-3B8F-4895-A475-1B70A988193F

Q33787916-BAACE394-2A75-4933-AC7A-DF87D97E000B

Q33787916-E1E23D30-5341-4152-8A7B-6C2C7531BF68

P2860

Q33787916-0343A67E-0A02-419D-87FB-A8F9F1EF1A5B

Q33787916-05F9A668-31FE-4E75-81A8-BEC36BB7AE2F

Q33787916-0ACB184F-F69F-4C2A-BA25-83F2F246AD11

Q33787916-0E03260C-F57B-4CE2-AF1D-14A8589CEF39

Q33787916-15B20D3D-74AC-44C4-B823-328C09ACA3EC

Q33787916-1C0A9F86-62E8-4FA0-BC44-8E30F9EDDB48

Q33787916-23840D2E-1EFE-4DD7-8D78-DB3A7588E0C2

Q33787916-23E27FAB-A03E-4D15-9C15-CFD16F52B638

Q33787916-3B9D1920-3D88-4AEF-8AA0-11ABC1A9939B

Q33787916-3F3B2DA0-EDFE-46B3-8AF1-32E56BD16DC2

P304

Q33787916-A0E52768-49D5-4650-BBA5-0EC0209F4003

P31

Q33787916-9083B815-D1AB-4D88-9B1D-5A5ED8DEC8FE

P356

Q33787916-8E8F4332-8421-4161-91E1-4D999680E8E6

P407

Q33787916-39153F51-A8AC-46EA-AB97-B590DB388518

P433

Q33787916-599E66AB-9BE5-4B39-987F-76F913C545C7

P478

Q33787916-A1CEF564-B341-4368-9A23-4626E2EF8162

P577

Q33787916-4F985E98-09AD-43D3-88B5-CBA13E813D69

P5875

Q33787916-736C4F19-4BC9-408B-89EF-AECC1B0E574C

P698

Q33787916-CC091BEB-3A11-4850-A1A8-340206355F95

P932

Q33787916-6B646EAC-4DA5-4EB4-875F-73D549A2A295

P356

P1433

World Journal of Gastroenterology

P1476

Sequential algorithms combinin ...... ibrosis in chronic hepatitis B

@en

P2093

Alessandro Vario

http://www.w3.org/2001/XMLSchema#string

Alfredo Alberti

http://www.w3.org/2001/XMLSchema#string

Giada Sebastiani

http://www.w3.org/2001/XMLSchema#string

Maria Guido

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, management, and treatment of hepatitis C

Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Natural history and prognostic factors for chronic hepatitis type B

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.

Liver biopsy sampling in chronic viral hepatitis.

P304

525-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I4.525

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6526966

http://www.w3.org/2001/XMLSchema#string

P698

17278217

http://www.w3.org/2001/XMLSchema#string

P932

4065973

http://www.w3.org/2001/XMLSchema#string